15499117

Source:http://linkedlifedata.com/resource/pubmed/id/15499117

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0040223, umls-concept:C0439234, umls-concept:C0441472, umls-concept:C1280477, umls-concept:C1369038, umls-concept:C1369039
pubmed:issue	7472
pubmed:dateCreated	2004-10-22
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-11589932, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-12022252, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-12748199, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-12777938, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-12958329, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-14615107, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-14764462, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-15499116, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-16037473, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-16254307, http://linkedlifedata.com/resource/pubmed/commentcorrection/15499117-8688776
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Indapamide, http://linkedlifedata.com/resource/pubmed/chemical/Perindopril
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1468-5833
pubmed:author	pubmed-author:ChalmersJohnJ, pubmed-author:MacmahonStephenS, pubmed-author:NealBruceB, pubmed-author:RodgersAnthonyA
pubmed:issnType	Electronic
pubmed:day	23
pubmed:volume	329
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	970-1
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15499117-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15499117-Antihypertensive Agents, pubmed-meshheading:15499117-Data Interpretation, Statistical, pubmed-meshheading:15499117-Double-Blind Method, pubmed-meshheading:15499117-Drug Therapy, Combination, pubmed-meshheading:15499117-Humans, pubmed-meshheading:15499117-Hypertension, pubmed-meshheading:15499117-Indapamide, pubmed-meshheading:15499117-Perindopril, pubmed-meshheading:15499117-Randomized Controlled Trials as Topic, pubmed-meshheading:15499117-Recurrence, pubmed-meshheading:15499117-Risk Factors, pubmed-meshheading:15499117-Stroke
pubmed:year	2004
pubmed:articleTitle	The PROGRESS trial three years later: time for more action, less distraction.
pubmed:affiliation	The George Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia.
pubmed:publicationType	Journal Article, Comment